Thrombotic and Hypercoagulability Complications of COVID-19: An Update
Review
[키워드] affecting
Anticoagulant
China
Clinical outcome
Complication
COVID-19
COVID-19 pandemic
COVID-19 patient
critically ill patients
develop
disease
endothelial cell damage
IMPROVE
incidence
include
increase
Inflammation
management
mechanism
outcome
pathophysiological mechanism
Pathways
poor prognosis
pro-inflammatory cytokines
Prognosis
Prophylactic
reported
Respiratory system
SARS-CoV-2
SARS-CoV-2 infected patients
Thromboembolism
thrombosis
thrombotic
thrombotic complication
thrombotic event
Treatment
[DOI] 10.2147/JBM.S316014 PMC 바로가기 [Article Type] Review
[DOI] 10.2147/JBM.S316014 PMC 바로가기 [Article Type] Review